Hospital deal volume in the first quarter of 2017 slipped further on concerns about repealing the Affordable Care Act.
Articles written by Lisa Phillips:
Biotechnology deal activity has climbed steadily over the past five quarters. The sector reached 62 transactions in Q1:17, an increase of 13% over the previous quarter and up 94% year-over-year. The total is 31% of the 203 deals announced in the previous 12 months. M&A in this sector will remain active for years to come, […]
Becton, Dickinson’s $24 billion deal for C.R. Bard helps it expand into markets outside the United States, and to treat diseases beyond diabetes.
Fresenius Medical Care has invested more than $5.1 billion in its U.S. pharmaceutical unit, Fresenius Kabi, in April 2017.
Envision Healthcare, which merged with AmSurg in December 2016, has rebranded its leading division as Physician Services. Good-bye, ambulatory surgery or medical transport.
Cardinal Health, Inc. announced its $6.1 billion acquisition of three Medtronic businesses on the same day it disappointed shareholders with its 2017 guidance update.
More than a year after Abbott and Alere agreed to merge, the lawsuits have been closed and the marriage is back on. The contract was renegotiated, of course.
Care Capital Properties, a healthcare REIT spun off from Ventas in 2015, acquired six behavioral health hospitals from Signature Healthcare.
Deals for medical device companies have slowed considerably since 2016. The sector seems to be gaining new life as the second quarter of 2017 begins.
Healthcare investors made a lot of deals in March, but spent 47% less than in February on those deals.